+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Psychobiotic Supplements Market by Product Type, Probiotic Strain, Source, Distribution Channel, Application, End-User - Global Forecast to 2030- Product Image
Psychobiotic Supplements Market by Product Type, Probiotic Strain, Source, Distribution Channel, Application, End-User - Global Forecast to 2030- Product Image
Sale

Psychobiotic Supplements Market by Product Type, Probiotic Strain, Source, Distribution Channel, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090378
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Psychobiotic Supplements Market grew from USD 372.84 million in 2024 to USD 406.58 million in 2025. It is expected to continue growing at a CAGR of 9.45%, reaching USD 641.11 million by 2030.

Harnessing the Power of Psychobiotics for Mental Wellbeing

The human microbiome has emerged as a frontier in the quest for improved mental wellbeing, and psychobiotic supplements sit at the center of this paradigm shift. Rooted in an evolving understanding of the gut-brain axis, these formulations harness specific live microorganisms to influence neurological and psychological outcomes. As consumer interest in holistic health escalates, psychobiotics have transcended niche status, attracting attention from research institutions, healthcare practitioners, and supplement manufacturers alike.

This report opens by tracing the scientific foundations underpinning psychobiotics, highlighting the interplay between gut microbiota and neurotransmitter activity. It examines the accelerating pace of clinical studies demonstrating potential benefits in stress reduction, mood modulation, and cognitive performance. Concurrently, it considers the broader wellness landscape, where mental health, personalized nutrition, and preventative care converge to propel demand for innovative supplement solutions.

By unpacking the critical drivers and challenges shaping this market, the introduction sets the stage for a detailed exploration of transformative shifts, regulatory headwinds, and strategic opportunities. It establishes a baseline from which stakeholders can navigate the complexities of product development, supply chain management, and consumer engagement in the dynamic realm of psychobiotics.

Emerging Drivers Reshaping the Psychobiotic Ecosystem

The psychobiotic sector is undergoing profound transformation as scientific discoveries, consumer behavior, and technological advancements coalesce. Personalized nutrition platforms now leverage genomic and microbiome data to tailor psychobiotic formulations for individual users, moving beyond one-size-fits-all approaches. Innovations in encapsulation and delivery technologies have improved strain viability, enabling products that maintain potency throughout shelf life and through the acidic environment of the gastrointestinal tract.

Simultaneously, digital health ecosystems are integrating psychobiotics into mental wellness journeys. Mobile applications track mood fluctuations and gut health metrics, facilitating real-time feedback loops between consumers and healthcare providers. This convergence of nutraceutical science and digital therapeutics fosters deeper engagement and adherence, while also generating valuable data streams for ongoing research and product refinement.

Corporate sustainability commitments have further reshaped the landscape, prompting the adoption of plant-based and upcycled raw materials in psychobiotic production. Manufacturers are investing in transparent sourcing and eco-friendly packaging to meet rising expectations around environmental responsibility. As the industry matures, strategic partnerships between biotechnology firms, academic institutions, and mental health practitioners are accelerating the translation of lab insights into market-ready innovations.

Navigating the Ripples of US Tariffs on Psychobiotic Trade

In 2025, new United States tariff regimes have introduced additional complexities for psychobiotic producers and importers. Tariffs on key probiotic raw materials, including select dairy-derived cultures and specialized nutrient carriers, have elevated input costs and prompted a reevaluation of global supply chains. Manufacturers are navigating between sourcing high-quality strains from traditional regions and exploring alternative suppliers to mitigate exposure to fluctuating trade policies.

These trade measures have ripple effects throughout the value chain. Ingredient procurement teams are renegotiating contracts, seeking volume discounts, and consolidating shipments to spread tariff burdens over larger deliveries. Product development units are exploring strain domestication closer to production facilities, reducing reliance on long-distance freight. Meanwhile, pricing strategies are under scrutiny, as brands balance margin preservation against competitive retail positioning.

On the consumer front, higher shelf prices risk dampening adoption rates, particularly in price-sensitive segments. Forward-looking companies are investing in cost optimization and supply chain transparency initiatives to reinforce value propositions. As a result of these tariff pressures, alliances between domestic growers and supplement manufacturers are gaining traction, fostering regional resilience and bolstering the agility required to thrive amid evolving trade landscapes.

Decoding Market Segments to Uncover Growth Opportunities

A nuanced understanding of market segments is essential to tailor psychobiotic offerings that resonate with varied customer needs. Product formulations span capsules renowned for dosage precision, chewables delivering convenience and palatability, liquid supplements favored for rapid absorption, and powder forms that enable flexible blending into foods and beverages. Strain selection is equally critical, with Bifidobacterium variants often associated with stress mitigation, Lactobacillus strains widely studied for gut barrier support, and Streptococcus thermophilus emerging for its synergistic effects in functional dairy products.

The origin of probiotic cultures is another axis of differentiation. Animal-based sources are prized for traditional strain diversity, while plant-based alternatives appeal to vegan and allergen-sensitive consumers seeking clean-label credentials. Distribution channels further diversify market reach. Offline retail footprints encompass pharmacies that emphasize clinical validation, specialty stores curating niche health offerings, and supermarkets and hypermarkets promoting broad accessibility. Online platforms complement physical outlets by enabling subscription models, targeted digital marketing, and data-driven customer relationship management.

Applications of psychobiotic ingredients extend beyond direct supplement intake. In animal feed, specific strains enhance livestock health and productivity, reflecting cross-industry opportunities. Functional foods and beverages incorporate psychobiotics into yogurt, tea blends, and nutrition bars to tap into snacking occasions. Nutritional supplements remain a cornerstone segment, with tailored dosage formats meeting daily wellness routines. The end-user demographic spectrum spans adults seeking stress relief, parents pursuing cognitive support for children, and older consumers focused on age-related cognitive maintenance. By weaving these segmentation lenses together, industry leaders can identify high-potential niches and craft differentiated value propositions.

Regional Dynamics Defining Psychobiotic Adoption Patterns

Regional market dynamics reveal distinct drivers and barriers to psychobiotic adoption. In the Americas, robust research infrastructures and high consumer awareness underpin rapid product innovation and premium positioning. Healthcare practitioners increasingly recommend psychobiotics as adjunct therapies, while direct-to-consumer marketing channels leverage social media and influencer partnerships to drive trial.

Europe, the Middle East, and Africa present a mosaic of regulatory frameworks, with the European Union’s stringent health claims legislation guiding product claims and labeling. Markets in the Gulf Cooperation Council are emerging as growth hotspots, buoyed by rising disposable incomes and expanding retail networks. In Africa, nascent distribution infrastructures and focus on local agricultural development create opportunities for plant-based psychobiotic solutions tied to regional crop economies.

Asia-Pacific remains a powerhouse for probiotics, with cultural legacies of fermented foods informing consumer receptivity. Countries such as Japan and South Korea have established clinical guidelines for live culture supplementation, fostering mainstream acceptance. Southeast Asian markets are witnessing the convergence of traditional herbal knowledge with modern microbiome science, while Australia and New Zealand leverage rigorous food safety standards to build global export reputations. These regional nuances guide strategic market entry and product adaptation plans.

Leading Innovators Shaping the Psychobiotic Market Landscape

The competitive landscape is shaped by established multinational food and beverage companies, specialty biotechnology firms, and emerging startups. Legacy players with extensive R&D budgets are expanding psychobiotic portfolios through strategic acquisitions and internal innovation pipelines. They invest in clinical trials to substantiate health claims and fortify trust among healthcare professionals.

Specialty ingredient suppliers differentiate through exclusive strain libraries and proprietary fermentation technologies. They forge partnerships with contract manufacturers and co-branders to expedite market launches, offering white-label solutions that meet stringent quality standards. Startups, on the other hand, capitalize on agility, pioneering novel delivery systems and leveraging crowd-sourced funding for niche product lines. They often target direct engagement with health-conscious communities, harnessing data analytics and social proof to drive early adoption.

Cross-sector collaborations are on the rise, with pharmaceutical companies exploring psychobiotics as adjunctive therapies and pet nutrition brands integrating behavioral health ingredients into animal feed. Such alliances reflect a convergence of expertise that accelerates product development cycles and broadens application horizons. As intellectual property portfolios expand, competitive differentiation increasingly hinges on clinical validation, supply chain transparency, and ecosystem partnerships that span academia, healthcare, and retail.

Strategic Imperatives to Capitalize on Psychobiotic Momentum

To thrive in this dynamic environment, industry players must pursue a multi-faceted strategy. Prioritizing personalized formulations based on microbiome profiling will enhance efficacy and consumer trust. Investing in scalable fermentation and encapsulation technologies can drive down production costs while ensuring strain viability. Strengthening supply chain resilience by diversifying raw material origins and forging strategic alliances with regional growers will mitigate tariff and logistical risks.

Engaging regulatory bodies early in product development fosters clarity around permissible health claims and expedites market approvals. Transparent communication of clinical evidence through peer-reviewed publications and healthcare practitioner outreach builds credibility. Concurrently, leveraging digital platforms for consumer education-through interactive content, mood tracking tools, and virtual consultations-will reinforce brand authority and foster community engagement.

Finally, integrating sustainability into every aspect of operations-from eco-conscious sourcing to recyclable packaging-will differentiate offerings in a crowded marketplace. By aligning business objectives with environmental stewardship and societal wellbeing, leaders can catalyze long-term growth and secure loyalty among increasingly values-driven consumers.

Rigorous Methodology Underpinning Market Insights

This report is grounded in a rigorous research framework combining primary and secondary methodologies. Primary insights were obtained through in-depth interviews with leading microbiologists, product developers, and regulatory experts, as well as surveys of end-users across demographics. These qualitative and quantitative inputs were triangulated to validate emerging trends and performance metrics.

Secondary research encompassed a comprehensive review of scientific journals, patent filings, regulatory databases, and industry publications. Historical trade data and tariff schedules were analyzed to assess the impact of policy shifts. Competitive intelligence was derived from company disclosures, clinical trial registries, and supply chain audits.

Data synthesis involved iterative validation sessions with subject-matter experts to ensure accuracy and relevance. Methodological rigor was maintained through standardized data collection protocols, transparent documentation of assumptions, and ongoing cross-verification against external benchmarks. This robust approach underpins the strategic and actionable insights presented throughout the report.

Synthesizing Insights for Next-Generation Psychobiotic Strategies

The convergence of scientific breakthroughs, shifting regulatory landscapes, and evolving consumer preferences positions the psychobiotic market at an inflection point. Stakeholders equipped with a deep understanding of segmentation nuances, regional dynamics, and competitive strategies are best positioned to capitalize on burgeoning opportunities.

Navigating the effects of trade policy fluctuations demands agility in sourcing and pricing strategies, while sustained investment in clinical validation will differentiate leading brands. The interplay between digital health solutions and traditional supplement formats offers a fertile ground for innovation, fostering stronger connections between consumers and mental wellbeing journeys.

By synthesizing the insights on transformative market shifts, tariff impacts, and strategic imperatives, decision-makers can craft resilient, growth-oriented roadmaps. The path forward calls for collaboration across science, industry, and regulation to unlock the full potential of psychobiotic supplements and usher in a new era of holistic mental health solutions.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Capsules
    • Chewables
    • Liquid Supplements
    • Powders
  • Probiotic Strain
    • Bifidobacterium
    • Lactobacillus
    • Streptococcus thermophilus
  • Source
    • Animal-Based
    • Plant-Based
  • Distribution Channel
    • Offline Retail
      • Pharmacies
      • Specialty Stores
      • Supermarkets & Hypermarkets
    • Online Retail
  • Application
    • Animal Feed
    • Functional Foods & Beverages
    • Nutritional Supplements
  • End-User
    • Adults
    • Children
    • Elderly
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Bened Life, Inc.
  • Danone SA
  • Dr. Ohhira’s Probiotics
  • DuPont de Nemours, Inc
  • Enzymedica Group
  • HUM Nutrition Inc.
  • iHerb, LLC
  • Institut AllergoSan Pharmaceuticals Research & Sales GmbH
  • Jarrow Formulas, Inc.
  • Kerry Group
  • Nestlé S.A
  • NortemChem SA
  • Novonesis Group
  • NOW Health Group, Inc.
  • Pendulum Therapeutics, Inc.
  • Probi AB
  • RHG & Company, Inc.
  • Seed Health, Inc.
  • Sova Health
  • Taylored Biotherapeutics
  • US Health & Wellbeing, LLC
  • WPP Company

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Psychobiotic Supplements Market, by Product Type
8.1. Introduction
8.2. Capsules
8.3. Chewables
8.4. Liquid Supplements
8.5. Powders

9. Psychobiotic Supplements Market, by Probiotic Strain
9.1. Introduction
9.2. Bifidobacterium
9.3. Lactobacillus
9.4. Streptococcus thermophilus

10. Psychobiotic Supplements Market, by Source
10.1. Introduction
10.2. Animal-Based
10.3. Plant-Based

11. Psychobiotic Supplements Market, by Distribution Channel
11.1. Introduction
11.2. Offline Retail
11.2.1. Pharmacies
11.2.2. Specialty Stores
11.2.3. Supermarkets & Hypermarkets
11.3. Online Retail

12. Psychobiotic Supplements Market, by Application
12.1. Introduction
12.2. Animal Feed
12.3. Functional Foods & Beverages
12.4. Nutritional Supplements

13. Psychobiotic Supplements Market, by End-User
13.1. Introduction
13.2. Adults
13.3. Children
13.4. Elderly

14. Americas Psychobiotic Supplements Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina

15. Europe, Middle East & Africa Psychobiotic Supplements Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland

16. Asia-Pacific Psychobiotic Supplements Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan

17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Bened Life, Inc.
17.3.3. Danone SA
17.3.4. Dr. Ohhira’s Probiotics
17.3.5. DuPont de Nemours, Inc
17.3.6. Enzymedica Group
17.3.7. HUM Nutrition Inc.
17.3.8. iHerb, LLC
17.3.9. Institut AllergoSan Pharmaceuticals Research & Sales GmbH
17.3.10. Jarrow Formulas, Inc.
17.3.11. Kerry Group
17.3.12. Nestlé S.A
17.3.13. NortemChem SA
17.3.14. Novonesis Group
17.3.15. NOW Health Group, Inc.
17.3.16. Pendulum Therapeutics, Inc.
17.3.17. Probi AB
17.3.18. RHG & Company, Inc.
17.3.19. Seed Health, Inc.
17.3.20. Sova Health
17.3.21. Taylored Biotherapeutics
17.3.22. US Health & Wellbeing, LLC
17.3.23. WPP Company

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

List of Figures
FIGURE 1. PSYCHOBIOTIC SUPPLEMENTS MARKET MULTI-CURRENCY
FIGURE 2. PSYCHOBIOTIC SUPPLEMENTS MARKET MULTI-LANGUAGE
FIGURE 3. PSYCHOBIOTIC SUPPLEMENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. PSYCHOBIOTIC SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. PSYCHOBIOTIC SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2024

List of Tables
TABLE 1. PSYCHOBIOTIC SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY CHEWABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY LIQUID SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STREPTOCOCCUS THERMOPHILUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ANIMAL-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 51. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 54. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 58. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 61. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 94. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 97. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 101. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 102. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 104. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 115. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 116. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 118. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 122. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 125. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 150. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 151. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 153. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 164. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 165. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 167. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. FINLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 171. FINLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. FINLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 174. FINLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. FINLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. EGYPT PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. EGYPT PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 192. EGYPT PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. EGYPT PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 195. EGYPT PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. EGYPT PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. TURKEY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. TURKEY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 199. TURKEY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 200. TURKEY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. TURKEY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 202. TURKEY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. TURKEY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. NORWAY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 213. NORWAY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. NORWAY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 216. NORWAY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. NORWAY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. POLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 220. POLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 221. POLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. POLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 223. POLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. POLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 240. CHINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. CHINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 242. CHINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 243. CHINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. CHINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 245. CHINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. CHINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. INDIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. INDIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 249. INDIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 250. INDIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. INDIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 252. INDIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. INDIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. JAPAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. JAPAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 256. JAPAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 257. JAPAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. JAPAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 259. JAPAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. JAPAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. THAILAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. THAILAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 284. THAILAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 285. THAILAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. THAILAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 287. THAILAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. THAILAND PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 324. PSYCHOBIOTIC SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 325. PSYCHOBIOTIC SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Psychobiotic Supplements market report include:
  • Abbott Laboratories
  • Bened Life, Inc.
  • Danone SA
  • Dr. Ohhira’s Probiotics
  • DuPont de Nemours, Inc
  • Enzymedica Group
  • HUM Nutrition Inc.
  • iHerb, LLC
  • Institut AllergoSan Pharmaceuticals Research & Sales GmbH
  • Jarrow Formulas, Inc.
  • Kerry Group
  • Nestlé S.A
  • NortemChem SA
  • Novonesis Group
  • NOW Health Group, Inc.
  • Pendulum Therapeutics, Inc.
  • Probi AB
  • RHG & Company, Inc.
  • Seed Health, Inc.
  • Sova Health
  • Taylored Biotherapeutics
  • US Health & Wellbeing, LLC
  • WPP Company

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 406.58 Million
Forecasted Market Value ( USD ) by 2030 $ 641.11 Million
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

2025 Psychobiotic Supplements Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Psychobiotic Supplements Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 147 Pages
  • Global
From
Psychobiotics Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Psychotropic Agent, By Form, By Application, By Region and Competition - Product Image

Psychobiotics Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Psychotropic Agent, By Form, By Application, By Region and Competition

  • Report
  • 110 Pages
  • Global
From
Microbiome Technologies for Nutraceuticals and Personal Care: Technology and Application Analysis - Product Image

Microbiome Technologies for Nutraceuticals and Personal Care: Technology and Application Analysis

  • Report
  • 56 Pages
  • Global
From
Molecular Mechanisms of Functional Food. Edition No. 1 - Product Image

Molecular Mechanisms of Functional Food. Edition No. 1

  • Book
  • 656 Pages
The Gut-Brain Axis. Dietary, Probiotic, and Prebiotic Interventions on the Microbiota. Edition No. 2 - Product Image

The Gut-Brain Axis. Dietary, Probiotic, and Prebiotic Interventions on the Microbiota. Edition No. 2

  • Book
Copyright © 2002-2025 Research and Markets. All Rights Reserved.